Skinvisible, Inc. (SKVI) stock
SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.16+0.00 (+0.06%)
Close on Oct 19, 2026Market cap $843.54KP/E –Yield –
Skinvisible total assets
Total assets on the balance sheet at the end of each period.
Skinvisible's total assets was $123.33K at Jun 30, 2026. For fiscal 2025 it was $127.57K, down 19.4% from the year before. Over ten years it grew -10.8% a year on average. The highest annual figure on record is $874.05K in fiscal 2013.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $127.57K | -19.4% |
| FY2024 | Dec 31, 2024 | $158.22K | -2.9% |
| FY2023 | Dec 31, 2023 | $162.87K | -34.0% |
| FY2022 | Dec 31, 2022 | $246.79K | +8.6% |
| FY2021 | Dec 31, 2021 | $227.30K | +13.5% |
| FY2020 | Dec 31, 2020 | $200.24K | +10.2% |
| FY2019 | Dec 31, 2019 | $181.76K | -17.5% |
| FY2018 | Dec 31, 2018 | $220.39K | -65.1% |
| FY2017 | Dec 31, 2017 | $632.19K | +86.2% |
| FY2016 | Dec 31, 2016 | $339.60K | -15.2% |
| FY2015 | Dec 31, 2015 | $400.53K | -38.0% |
| FY2014 | Dec 31, 2014 | $646.05K | -26.1% |
| FY2013 | Dec 31, 2013 | $874.05K | +15.9% |
| FY2012 | Dec 31, 2012 | $754.25K | +154.0% |
| FY2011 | Dec 31, 2011 | $296.92K | +8.8% |
| FY2010 | Dec 31, 2010 | $273.01K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $123.33K | -14.0% |
| Q1 FY2026 | Mar 31, 2026 | $119.42K | -20.1% |
| Q4 FY2025 | Dec 31, 2025 | $127.57K | -19.4% |
| Q3 FY2025 | Sep 30, 2025 | $133.62K | -10.1% |
| Q2 FY2025 | Jun 30, 2025 | $143.38K | -12.1% |
| Q1 FY2025 | Mar 31, 2025 | $149.55K | -2.5% |
| Q4 FY2024 | Dec 31, 2024 | $158.22K | -2.9% |
| Q3 FY2024 | Sep 30, 2024 | $148.64K | -19.7% |
| Q2 FY2024 | Jun 30, 2024 | $163.06K | -16.9% |
| Q1 FY2024 | Mar 31, 2024 | $153.40K | -25.5% |
| Q4 FY2023 | Dec 31, 2023 | $162.87K | -34.0% |
| Q3 FY2023 | Sep 30, 2023 | $185.06K | -33.7% |
| Q2 FY2023 | Jun 30, 2023 | $196.32K | -38.8% |
| Q1 FY2023 | Mar 31, 2023 | $205.86K | -9.4% |
| Q4 FY2022 | Dec 31, 2022 | $246.79K | +14.4% |
| Q3 FY2022 | Sep 30, 2022 | $279.16K | +21.0% |
| Q2 FY2022 | Jun 30, 2022 | $320.59K | +90.0% |
| Q4 FY2021 | Dec 31, 2021 | $227.30K | +13.5% |
| Q3 FY2021 | Sep 30, 2021 | $215.77K | +17.2% |
| Q2 FY2021 | Jun 30, 2021 | $230.80K | +6.6% |
| Q1 FY2021 | Mar 31, 2021 | $168.75K | -3.4% |
| Q4 FY2020 | Dec 31, 2020 | $200.24K | +10.2% |
| Q3 FY2020 | Sep 30, 2020 | $184.10K | -11.5% |
| Q2 FY2020 | Jun 30, 2020 | $216.57K | +2.6% |
| Q1 FY2020 | Mar 31, 2020 | $174.77K | -14.5% |
| Q4 FY2019 | Dec 31, 2019 | $181.76K | -17.5% |
| Q3 FY2019 | Sep 30, 2019 | $208.08K | -8.8% |
| Q2 FY2019 | Jun 30, 2019 | $211.15K | -46.6% |
| Q1 FY2019 | Mar 31, 2019 | $204.45K | -52.0% |
| Q4 FY2018 | Dec 31, 2018 | $220.39K | -65.1% |
| Q3 FY2018 | Sep 30, 2018 | $228.08K | -61.4% |
| Q2 FY2018 | Jun 30, 2018 | $395.35K | -25.5% |
| Q1 FY2018 | Mar 31, 2018 | $426.03K | +32.4% |
| Q4 FY2017 | Dec 31, 2017 | $632.19K | +86.2% |
| Q3 FY2017 | Sep 30, 2017 | $590.42K | +68.4% |
| Q2 FY2017 | Jun 30, 2017 | $530.54K | +43.1% |
| Q1 FY2017 | Mar 31, 2017 | $321.83K | – |
| Q4 FY2016 | Dec 31, 2016 | $339.60K | – |
| Q3 FY2016 | Sep 30, 2016 | $350.70K | – |
| Q2 FY2016 | Jun 30, 2016 | $370.63K | – |
See a number that looks wrong?